Search results for "Highlights"
Spotlight on inpatient hyperglycemia
A new guideline offered recommendations on managing hyperglycemia in hospital patients with or without diabetes. Recent studies looked at the effects of elevated blood glucose levels after surgery and in the ICU.
https://diabetes.acponline.org/archives/2022/07/08/5.htm
8 Jul 2022
Dietary protein sources associated with type 2 diabetes risk, study finds
Data from the Women's Health Initiative indicated that when 5% of energy intake from plant protein was substituted for animal protein, type 2 diabetes risk was estimated to decrease by approximately 21%.
https://diabetes.acponline.org/archives/2022/07/08/3.htm
8 Jul 2022
Disparities by race, hospital type exist in diabetes-related lower-extremity amputations
The authors of a recent study called for public awareness, screening, and accessible and early multidisciplinary care, as well as neighborhood-level public health interventions, to reduce the disproportionate burden of lower-extremity amputation in underserved communities.
https://diabetes.acponline.org/archives/2022/07/08/2.htm
8 Jul 2022
DPP-4 inhibitors associated with risk of cholecystitis, meta-analysis finds
Patients with type 2 diabetes who were randomized to receive dipeptidyl peptidase-4 (DPP-4) inhibitors had higher rates of gallbladder disease than those who got placebo or nonincretin drugs, but no difference in risk of cholelithiasis or biliary diseases.
https://diabetes.acponline.org/archives/2022/07/08/1.htm
8 Jul 2022
Report and study highlight risk of heart failure in patients with diabetes
The American Diabetes Association made recommendations on diagnosing and treating heart failure in patients with diabetes, and a study found increased risk of progression to clinical heart failure in those with an HbA1c level of 7% or above.
https://diabetes.acponline.org/archives/2022/06/10/1.htm
10 Jun 2022
SGLT-2 inhibitors associated with reduced heart failure events versus metformin
A retrospective study of patients who took sodium-glucose cotransporter-2 (SGLT-2) inhibitors or metformin as first-line therapy for type 2 diabetes found similar risk for myocardial infarction and stroke with the two drug classes but a difference in hospitalizations for heart failure.
https://diabetes.acponline.org/archives/2022/06/10/2.htm
10 Jun 2022
Whole, plant-based diet most effective for type 2 diabetes remission, ACLM says
Diet as a primary intervention can achieve remission for many with type 2 diabetes and should focus on plant-based foods with minimal consumption of meat and other animal products, according to a statement from the American College of Lifestyle Medicine (ACLM).
https://diabetes.acponline.org/archives/2022/06/10/3.htm
10 Jun 2022
HbA1c, CGM data significantly differed in patients with kidney disease
Patients with diabetes and chronic kidney disease often had discordance between their HbA1c levels and continuous glucose monitoring (CGM) data, with the HbA1c being significantly higher on average than the CGM-calculated glucose, a French study found.
https://diabetes.acponline.org/archives/2022/05/13/2.htm
13 May 2022
Cystatin C levels associated with risk of sight-threatening diabetic retinopathy
The biomarker may be useful for predicting this condition, especially in areas that don't have access to retinal imaging, according to an analysis of ophthalmology patients in the United Kingdom and India.
https://diabetes.acponline.org/archives/2022/05/13/3.htm
13 May 2022
Spotlight on efficacy of SGLT-2 inhibitors and GLP-1 receptor agonists
One recent study compared sodium-glucose cotransporter-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists to each other, a meta-analysis tried to quantify their benefits compared to placebo, and a third study looked at their effects relative to insulin.
https://diabetes.acponline.org/archives/2022/05/13/5.htm
13 May 2022